Edition:
India

Depomed Inc (DEPO.OQ)

DEPO.OQ on NASDAQ Stock Exchange Global Select Market

6.78USD
1:30am IST
Change (% chg)

$-0.24 (-3.42%)
Prev Close
$7.02
Open
$6.97
Day's High
$7.06
Day's Low
$6.67
Volume
251,467
Avg. Vol
356,784
52-wk High
$12.49
52-wk Low
$4.32

Select another date:

Tue, Apr 3 2018

BRIEF-Depomed Appoints Stan Bukofzer As Chief Medical And Scientific Officer

* DEPOMED ANNOUNCES THE APPOINTMENT OF STAN BUKOFZER, M.D. AS SENIOR VICE PRESIDENT AND CHIEF MEDICAL AND SCIENTIFIC OFFICER Source text for Eikon: Further company coverage:

BRIEF-Depomed Inc Files For Mixed Shelf Of Up To $300 Million‍​

* DEPOMED INC FILES FOR MIXED SHELF OF UP TO $300 MILLION - SEC FILING ‍​ Source text (http://bit.ly/2oD3GLe) Further company coverage:

BRIEF-Depomed Reports Q4 GAAP Loss Per Share $0.52

* ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

BRIEF-Depomed Announces Nucynta® Commercialization Agreement With Collegium Pharmaceutical

* DEPOMED ANNOUNCES NUCYNTA® COMMERCIALIZATION AGREEMENT WITH COLLEGIUM PHARMACEUTICAL

BRIEF-Collegium To License Rights To Commercialize Nucynta Franchise

* COLLEGIUM TO LICENSE RIGHTS TO COMMERCIALIZE NUCYNTA FRANCHISE

BRIEF-Depomed announces Q3 loss of $0.25 per share

* Depomed inc sees ‍2017 non-gaap total revenue $380 to $385 million​

BRIEF-Depomed and Slán Medicinal Holdings announce strategic asset transactions

* Depomed and Slán Medicinal Holdings Ltd announce strategic asset transactions

BRIEF-PDL Biopharma announces settlement agreement with Valeant

* PDL Biopharma - ‍Valeant to pay a one-time, lump-sum payment of $13.0 million as part of settlement

Select another date: